Media Partner
Sophia Karagiannis
UK
EVENT WILL START IN
Location
Athens, Greece
Dates
01-03 December 2022
Speakers
39 Professionals
Welcome Address
Dear Friends and Colleagues,
It is a great pleasure to welcome you to the “8th Symposium “Advances in Cancer Immunology & Immunotherapy” in the city of Athens, Greece.
The 8th Symposium “Advances in Cancer Immunology & Immunotherapy” is an intensive, three days interactive meeting during which invited speakers will address the current and accumulated knowledge of basic immuno-biology and translational cancer research, as well as therapeutic developments in the field of cancer immunotherapy according to the newest clinical trials.
The scientific objectives of the 8th Symposium “Advances in Cancer Immunology and Immunotherapy” are focused on the: (a) predictive and prognostic biomarkers for immunotherapy (b) mechanisms of action of different immunotherapeutic treatments (c) the efficacy and safety data of cancer immunotherapy regimens; and (d) strategies for immunomodulation, counteracting resistance and mitigating adverse events.
This year’s Symposium will feature world-renowned oncologists and researchers who will provide their insights on the above mentioned topics in an effort to better understand tumor evolution and designing improved treatment strategies.
The 8th Symposium “Advances in Cancer Immunology and Immunotherapy” welcome the participation of scientists, clinicians, students and health care professionals interested in the field of Cancer Immunology and Immunotherapy.
We would like to thank you for your participation and we are looking forward to seeing you in Athens.
Warm regards,
The Organizing Committee
Athanasios Kotsakis
MD, PhD, Professor of Medical Oncology, School of Medicine, University of Thessaly, Larissa , Greece
Ourania Tsitsilonis
MD, PhD, Professor of Immunology, Department of Biology, National and Kapodistrian University of Athens, Greece
Constantin N. Baxevanis
Scientific Director, Cancer Immunology and Immunotherapy Center “St.Savvas” Cancer Hospital, Athens, Greece
Graham Pawelec
Professor of Experimental Immunology, Center of Medical Research, Department of Immunology, University of Tuebingen, Germany
Monica Neagu
Head of Immunology Department, “Victor Babes” National Institute of Pathology, Bucharest, Romania President of the Romanian Immunology Society, Romania
Suzanne Ostrand-Rosenberg
Adjunct Professor of Pathology Huntsman Cancer Institute (HCL),
University of Utah, USA
Jörg Wischhusen
Professor of Experimental Tumor Immunology University of Würzburg School of Medicine Department of Gynecology and Obstetrics, Germany
Event's Confirmed Speakers
Gosse Adema, NL
Vincenzo Bronte, ΙΤ
Marianna Christodoulou, CY
Pierre Coulie, BE
Alexandra Drakaki, USΑ
Teresa Frisan, SE
Lorenzo Galluzzi, USΑ
Petros Grivas, USΑ
Ulrich Keilholz, DE
Else Marit Inderberg, NO
Sofia Karagiannis, UK
Greg Kirchenbaum, USA
Michael Koukourakis, GR
Alejandro Madrigal, UK
Dimitris Mastellos, GR
Alexios Matikas, SE
Gilles Maradon, FR
Noel de Miranda, ES
Monica Neagu, RO
Daniel Öhlund, SE
Patrick Ott, USA
Dionysios Papadatos – Pastos, UK
Annette Paschen, DE
Ioannis S. Pateras, GR
Graham Pawelec, DE
Hans – Georg Rammensee, DE
Christoph Reinhardt, DE
Suzanne Ostrand – Rosenberg, USA
Barbara Seliger, DE
Ferdinandos Skoulidis, USA
Viktor Umansky, DE
Panayiotis Verginis, GR
Teresa Whiteside, USA
Jörg Wischhusen, DE
Media Partner
Event Sessions
Session 1: Tumor Immunity and Immunomodulation
Session 2: Cancer Vaccines
Session 3: Skin Neoplasms and Head and Neck Cancer – Current Status of Immunotherapy and Future Perspectives
Session 4: Cancer Biomarkers and Advances in Cancer Treatments
Session 5: Advances in Anti-cancer Immunotherapeutic Approaches
Session 6: Gynecological Cancers and Breast Cancer – Current Status of Immunotherapy and Future perspectives
Session 7: Urinary Tract Neoplasms: Current Challenges and Future Perspectives
Session 8: Intrinsic Regulation of Antitumor Immune Responses
Session 9: Extrinsic Regulation of Antitumor Immune Responses
Session 10: Immunotherapy in Lung Cancer: Current Challenges and Future Perspectives
Session 11: Cancer Immunotherapy in 2022 and a look ahead
Event's Abstract Submission
The Scientific Committee welcomes the submission of abstracts to the 8th Symposium on Advances in Cancer Immunology & Immunotherapy. Abstracts must be submitted in English through this website. Abstracts will be selected on scientific merit. An individual can submit one or more abstracts as presenter or first author. Abstract submission will open from May 16th 2022.
Our Speakers
Our Sponsors
Under the Auspices of
